- Home
- MMA vs PHIO Comparison
MMA vs PHIO Comparison
Compare MMA & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- PHIO
- Stock Information
- Founded
- MMA 2013
- PHIO 2011
- Country
- MMA Australia
- PHIO United States
- Employees
- MMA N/A
- PHIO N/A
- Industry
- MMA
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- PHIO Health Care
- Exchange
- MMA Nasdaq
- PHIO Nasdaq
- Market Cap
- MMA 11.1M
- PHIO 10.5M
- IPO Year
- MMA 2024
- PHIO N/A
- Fundamental
- Price
- MMA $0.94
- PHIO $2.09
- Analyst Decision
- MMA
- PHIO Strong Buy
- Analyst Count
- MMA 0
- PHIO 3
- Target Price
- MMA N/A
- PHIO $10.67
- AVG Volume (30 Days)
- MMA 752.0K
- PHIO 231.2K
- Earning Date
- MMA 01-01-0001
- PHIO 08-14-2025
- Dividend Yield
- MMA N/A
- PHIO N/A
- EPS Growth
- MMA N/A
- PHIO N/A
- EPS
- MMA N/A
- PHIO N/A
- Revenue
- MMA $407,412.00
- PHIO N/A
- Revenue This Year
- MMA N/A
- PHIO N/A
- Revenue Next Year
- MMA N/A
- PHIO N/A
- P/E Ratio
- MMA N/A
- PHIO N/A
- Revenue Growth
- MMA N/A
- PHIO N/A
- 52 Week Low
- MMA $0.60
- PHIO $0.97
- 52 Week High
- MMA $4.11
- PHIO $9.79
- Technical
- Relative Strength Index (RSI)
- MMA 48.81
- PHIO 39.36
- Support Level
- MMA $0.79
- PHIO $1.91
- Resistance Level
- MMA $1.08
- PHIO $2.29
- Average True Range (ATR)
- MMA 0.11
- PHIO 0.14
- MACD
- MMA 0.00
- PHIO -0.02
- Stochastic Oscillator
- MMA 54.52
- PHIO 32.14
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.